Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1741 AL 1755

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case report

Mirallas O, Saoudi N, Gómez-Puerto D, Riveiro-Barciela M, Merino X, Auger C, Landolfi S, Blanco L, Garcia-Burillo A, Molero X, Salcedo-Allende MT, Capdevila J.

World J Hepatol. 2021 May 27;13(5):611-619. doi: 10.4254/wjh.v13.i5.611.

The Gastrointestinal Dysfunction Scale for Parkinson's Disease

Camacho M, Greenland JC, Williams-Gray CH.

Mov Disord. 2021 Oct;36(10):2358-2366. doi: 10.1002/mds.28675. Epub 2021 Jun 16.

ATP-sensitive potassium channels: key players in pathophysiology of many diseases

Bláhová K, Bébarová M.

Cas Lek Cesk. 2021 Spring;160(2-3):71-80.

Systemic Disease Associations with Disorders of Gut-Brain Interaction and Gastrointestinal Transit: A Review

Moudgal R, Schultz AW, Shah ED.

Clin Exp Gastroenterol. 2021 Jun 8;14:249-257. doi: 10.2147/CEG.S283685. eCollection 2021.

Multitarget therapeutic approaches for Alzheimer's and Parkinson's diseases: an opportunity or an illusion?

Matos MJ.

Future Med Chem. 2021 Aug;13(15):1301-1309. doi: 10.4155/fmc-2021-0119. Epub 2021 Jun 17.

A Randomized, Placebo-Controlled Crossover Study with Dipyridamole for Restless Legs Syndrome

Garcia-Borreguero D, Garcia-Malo C, Granizo JJ, Ferré S.

Mov Disord. 2021 Oct;36(10):2387-2392. doi: 10.1002/mds.28668. Epub 2021 Jun 17.

Effect of dietary vitamins C and E on the risk of Parkinson's disease: A meta-analysis

Chang MC, Kwak SG, Kwak S.

Clin Nutr. 2021 Jun;40(6):3922-3930. doi: 10.1016/j.clnu.2021.05.011. Epub 2021 May 21.

The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease

Abbruzzese G, Barone P, Lopiano L, Stocchi F.

Drug Des Devel Ther. 2021 Jun 10;15:2507-2517. doi: 10.2147/DDDT.S302673. eCollection 2021.

Switch from rasagiline to safinamide in fluctuating Parkinson's disease patients: a retrospective, pilot study

Bianchini E, Sforza M, Rinaldi D, Alborghetti M, De Carolis L, Della Gatta F, Pontieri FE.

Neurol Res. 2021 Nov;43(11):950-954. doi: 10.1080/01616412.2021.1942408. Epub 2021 Jun 18.

Successful Ablation of an Epicardial Accessory Pathway via the Subxiphoid Approach in a Child

Dalili M.

Indian Pacing Electrophysiol J. 2021 Sep-Oct;21(5):316-320. doi: 10.1016/j.ipej.2021.06.002. Epub 2021 Jun 16.

A novel FBXO7-R345P mutation in a Chinese family with autosomal recessive parkinsonian-pyramidal syndrome

Wang Z, Song Y, Zhu W, Wang X, Li X, Xu F, Si L, Yao T, Zhu J, Lai H, Li W, Lin F, Wang C.

Parkinsonism Relat Disord. 2021 Jul;88:62-67. doi: 10.1016/j.parkreldis.2021.06.005. Epub 2021 Jun 10.

In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study

Grothe MJ, Labrador-Espinosa MA, Jesús S, Macías-García D, Adarmes-Gómez A, Carrillo F, Camacho EI, Franco-Rosado P, Lora FR, Martín-Rodríguez JF, Barberá MA, Pastor P, Arroyo SE, Vila BS, Foraster AC, Martínez JR, Padilla FC, Morlans MP, Aramburu IG, Ceberio JI, Vara JH, de Fábregues-Boixar O, de Deus Fonticoba T, Pascual-Sedano B; COPPADIS Study Group; Kulisevsky J, Martínez-Martín P, Santos-García D, Mir P.

Parkinsonism Relat Disord. 2021 Jul;88:68-75. doi: 10.1016/j.parkreldis.2021.05.027. Epub 2021 May 31.

Communicating chronic hydrocephalus: A review

Roblot P, Mollier O, Ollivier M, Gallice T, Planchon C, Gimbert E, Danet M, Renault S, Auzou N, Laurens B, Jecko V.

Rev Med Interne. 2021 Nov;42(11):781-788. doi: 10.1016/j.revmed.2021.05.018. Epub 2021 Jun 16.

Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment

Bang Y, Lim J, Choi HJ.

Arch Pharm Res. 2021 Jun;44(6):588-604. doi: 10.1007/s12272-021-01337-3. Epub 2021 Jun 19.

Counting What Counts: How to Reach Outcomes That Truly Matter to Parkinson's Patients

Mathur S.

Mov Disord. 2021 Jun;36(6):1290-1292. doi: 10.1002/mds.28587.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias